3A7T
| |
3A83
| |
3A82
| |
3A8D
| |
3A89
| |
3A84
| |
3A7Z
| |
3A8B
| |
3A81
| |
3A7Y
| |
3A8A
| |
3ATK
| Crystal structure of trypsin complexed with cycloheptanamine | Descriptor: | CALCIUM ION, Cationic trypsin, DIMETHYL SULFOXIDE, ... | Authors: | Yamane, J, Yao, M, Tanaka, I. | Deposit date: | 2011-01-05 | Release date: | 2011-08-24 | Last modified: | 2024-10-30 | Method: | X-RAY DIFFRACTION (1.74 Å) | Cite: | In-crystal affinity ranking of fragment hit compounds reveals a relationship with their inhibitory activities J.Appl.Crystallogr., 44, 2011
|
|
3ATI
| Crystal structure of trypsin complexed with (3-methoxyphenyl)methanamine | Descriptor: | 1-(3-methoxyphenyl)methanamine, CALCIUM ION, Cationic trypsin, ... | Authors: | Yamane, J, Yao, M, Tanaka, I. | Deposit date: | 2011-01-05 | Release date: | 2011-08-24 | Last modified: | 2023-11-01 | Method: | X-RAY DIFFRACTION (1.71 Å) | Cite: | In-crystal affinity ranking of fragment hit compounds reveals a relationship with their inhibitory activities J.Appl.Crystallogr., 44, 2011
|
|
3ATM
| Crystal structure of trypsin complexed with 2-(1H-indol-3-yl)ethanamine | Descriptor: | 2-(1H-INDOL-3-YL)ETHANAMINE, CALCIUM ION, Cationic trypsin, ... | Authors: | Yamane, J, Yao, M, Tanaka, I. | Deposit date: | 2011-01-05 | Release date: | 2011-08-24 | Last modified: | 2024-10-16 | Method: | X-RAY DIFFRACTION (1.72 Å) | Cite: | In-crystal affinity ranking of fragment hit compounds reveals a relationship with their inhibitory activities J.Appl.Crystallogr., 44, 2011
|
|
3ATL
| Crystal structure of trypsin complexed with benzamidine | Descriptor: | BENZAMIDINE, CALCIUM ION, Cationic trypsin, ... | Authors: | Yamane, J, Yao, M, Tanaka, I. | Deposit date: | 2011-01-05 | Release date: | 2011-08-24 | Last modified: | 2023-11-01 | Method: | X-RAY DIFFRACTION (1.74 Å) | Cite: | In-crystal affinity ranking of fragment hit compounds reveals a relationship with their inhibitory activities J.Appl.Crystallogr., 44, 2011
|
|
3A85
| |
3A80
| |
3A8C
| |
3A7X
| |
3A86
| |
3VOB
| Staphylococcus aureus FtsZ with PC190723 | Descriptor: | 3-[(6-chloro[1,3]thiazolo[5,4-b]pyridin-2-yl)methoxy]-2,6-difluorobenzamide, CALCIUM ION, Cell division protein FtsZ, ... | Authors: | Yamane, J, Matsui, T, Mogi, N, Yamaguchi, H, Takemoto, H, Yao, M, Tanaka, I. | Deposit date: | 2012-01-20 | Release date: | 2012-08-29 | Last modified: | 2023-11-08 | Method: | X-RAY DIFFRACTION (2.703 Å) | Cite: | Structural reorganization of the bacterial cell-division protein FtsZ from Staphylococcus aureus Acta Crystallogr.,Sect.D, 68, 2012
|
|
3VOA
| Staphylococcus aureus FtsZ 12-316 GDP-form | Descriptor: | CALCIUM ION, Cell division protein FtsZ, GUANOSINE-5'-DIPHOSPHATE | Authors: | Yamane, J, Matsui, T, Mogi, N, Yao, M, Tanaka, I. | Deposit date: | 2012-01-20 | Release date: | 2012-08-29 | Last modified: | 2023-11-08 | Method: | X-RAY DIFFRACTION (1.73 Å) | Cite: | Structural reorganization of the bacterial cell-division protein FtsZ from Staphylococcus aureus Acta Crystallogr.,Sect.D, 68, 2012
|
|
3VPA
| Staphylococcus aureus FtsZ apo-form | Descriptor: | Cell division protein FtsZ | Authors: | Matsui, T, Yamane, J, Mogi, N, Yao, M, Tanaka, I. | Deposit date: | 2012-02-28 | Release date: | 2012-08-29 | Last modified: | 2023-11-08 | Method: | X-RAY DIFFRACTION (2.487 Å) | Cite: | Structural reorganization of the bacterial cell-division protein FtsZ from Staphylococcus aureus Acta Crystallogr.,Sect.D, 68, 2012
|
|
3VO9
| Staphylococcus aureus FtsZ apo-form (SeMet) | Descriptor: | Cell division protein FtsZ | Authors: | Matsui, T, Yamane, J, Mogi, N, Yao, M, Tanaka, I. | Deposit date: | 2012-01-20 | Release date: | 2012-08-29 | Last modified: | 2013-08-14 | Method: | X-RAY DIFFRACTION (2.706 Å) | Cite: | Structural reorganization of the bacterial cell-division protein FtsZ from Staphylococcus aureus Acta Crystallogr.,Sect.D, 68, 2012
|
|
7VU6
| The crystal structure of SARS-CoV-2 3CL protease in complex with compound 3 | Descriptor: | 3C-like proteinase, 6-[(6-chloranyl-2-methyl-indazol-5-yl)amino]-3-[(1-methyl-1,2,4-triazol-3-yl)methyl]-1-[[2,4,5-tris(fluoranyl)phenyl]methyl]-1,3,5-triazine-2,4-dione | Authors: | Yamamoto, S, Yamane, J, Tachibana, Y. | Deposit date: | 2021-11-01 | Release date: | 2022-04-06 | Last modified: | 2023-11-29 | Method: | X-RAY DIFFRACTION (1.8 Å) | Cite: | Discovery of S-217622, a Noncovalent Oral SARS-CoV-2 3CL Protease Inhibitor Clinical Candidate for Treating COVID-19. J.Med.Chem., 65, 2022
|
|